Similar to This
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs: Novo stock popped early Wednesday on better-than-expected third-quarter sales and ...
investors.com/news/technology/novo-stock-novo-earnings-q3-2026/
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs
Novo Nordisk lifts 2026 outlook as Wegovy pill surges: Weight-loss pill sales surge 53% in third quarter, beating analyst forecasts
timeslive.co.za/news/world/2026-11-04-novo-nordisk-lifts-2026-outlook-as-wegovy-pill-surges/
Novo Nordisk lifts 2026 outlook as Wegovy pill surges
Zepbound grew 174.9% in 2025, the fastest rate among the top 10 drugs: Seven of the best-selling drugs of 2026 from GEN's top 10, ranked by 2025 sales ...
qz.com/best-selling-drugs-2026-2025-sales
Zepbound grew 174.9% in 2025, the fastest rate among the top 10 drugs
Lilly's next-gen weight loss drug more than doubled Novo Nordisk's in trial: Retatrutide lowered A1C, a blood sugar measure, by 2.2% versus 1.8% for Ozempic ...
qz.com/lilly-retatrutide-ozempic-weight-loss-trial-102826
Lilly's next-gen weight loss drug more than doubled Novo Nordisk's in ...
DAX falls - | Novo Nordisk, Meta, Nvidia, Porsche, Beiersdorf, Apple, Eli Lilly, Cancom
boerse-online.de/nachrichten/aktien/dax-faellt-novo-nordisk-meta-nvidia-porsche-beiersdorf-apple-eli-lilly-cancom-20425362.html
DAX falls - | Novo Nordisk, Meta, Nvidia, Porsche, Beiersdorf, Apple ...
Weight-loss medications: Eli Lilly soaring, Novo Nordisk in freefall: Novo Nordisk expects a sales decline of up to 6 percent. Competitor Eli Lilly ...
manager-magazin.de/unternehmen/pharma/eli-lilly-us-konzern-im-hoehenflug-novo-nordisk-rechnet-mit-rueckgaengen-a-839421a1-543a-49a2-aec1-d4b8f1e13d41
Weight-loss medications: Eli Lilly soaring, Novo Nordisk in freefall
Novo Nordisk: Forecast up, but...: Novo Nordisk raises its sales forecast due to the success of the Wegovy weight-loss pill and now expects a decline of no more ...
deraktionaer.de/artikel/aktien/novo-nordisk-prognose-rauf-aber-20406085.html
Novo Nordisk: Forecast up, but...
Novo Nordisk stock under pressure: Competition, IPO, pill race, billion-dollar deal: How the situation is changing for Novo Nordisk
finanzen.net/nachricht/aktien/adipositas-markt-novo-nordisk-aktie-unter-druck-wettbewerb-verschaerft-sich-neue-rivalen-neue-pillen-00-15620444
Novo Nordisk stock under pressure: Competition, IPO, pill race ...
In Novo Nordisk's slipstream: Danish pharmaceutical IPO ahead?: Danish pharmaceutical company LEO Pharma is apparently planning an IPO with a focus on skin ...
deraktionaer.de/artikel/pharma-biotech/im-windschatten-von-novo-nordisk-daenisches-pharma-ipo-voraus-20397245.html
In Novo Nordisk's slipstream: Danish pharmaceutical IPO ahead?
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
cnbc.com/2026/02/04/eli-lilly-novo-nordisk-earnings-glp1-market.html
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces ...
Novo Nordisk: Investors hesitant - | important date ahead: Novo Nordisk share stabilizes, analysts skeptical ahead of Q4 report on Feb 4; focus on Wegovy.
deraktionaer.de/artikel/deraktionaerplus/novo-nordisk-anleger-zoegern-wichtiger-termin-voraus-20393910.html
Novo Nordisk: Investors hesitant - | important date ahead
Novo Nordisk: Advantage over Eli Lilly - | chart breakout ahead?: Novo Nordisk's new weight-loss pill on the US market, CEO sees advantages over injectable ...
deraktionaer.de/artikel/deraktionaerplus/novo-nordisk-vorteil-gegenueber-eli-lilly-charttechnischer-ausbruch-voraus-20393398.html
Novo Nordisk: Advantage over Eli Lilly - | chart breakout ahead?